Wie sind die Öffnungszeiten?

Montag 09:00 - 17:00 Dienstag 09:00 - 17:00 Mittwoch 09:00 - 17:00 Donnerstag 09:00 - 17:00 Freitag 09:00 - 17:00

European Association of Nuclear Medicine - EANM

Startseite
österreich
Vienna
European Association of Nuclear Medicine - EANM

The European Association of Nuclear Medicine (EANM) is the largest non-profit medical organisation dedicated to nuclear medicine in Europe.

The EANM is the largest non-profit medical organisation dedicated to nuclear medicine in Europe. Since its establishment in 1985, the EANM has consistently aimed to provide an interactive platform for the sharing and discussion of cutting-edge developments in the field, fostering the exchange of knowledge on disease diagnosis and treatment. Nuclear medicine is a multi-professional, independent, me

dical discipline based on the application of probes labelled with radionuclides (radiopharmaceuticals) to both diagnose and treat various diseases, such as cancer. Its scope encompasses molecular imaging, image-guided procedures, and targeted radionuclide therapy. Nuclear medicine procedures target specific physio-pathological processes or features underlying a disease directly at the molecular level. Employing sophisticated hybrid technology and a multimodal approach, nuclear medicine ensures a comprehensive diagnostic map, fostering precision medicine to diagnose, prognosticate, administer targeted therapy, guide treatment, and monitor its effects on patients. As a leading organisation in the field, the EANM brings together professionals from different backgrounds, including nuclear medicine physicians, medical physicists, radiochemists, pharmacists, technologists and other experts working in nuclear medicine or related fields. The EANM also works closely with 40 European nuclear medicine national societies, 20 non-European affiliated societies, EU institutions, international bodies and other medical societies to bring nuclear medicine to the forefront. Globally recognised for its Annual Congress, which attracts more than 7,000 attendees each year, the EANM is also the driving force behind the European School of Multimodality Imaging & Therapy (ESMIT). ESMIT offers a broad spectrum of educational programmes designed to enhance expertise in the field.

08/09/2026

Throwback to great discussions at the Total Body PET Conference at UC Davis last week, where Prof. Dr. Ronald Boellaard presented EARL’s initial results on a prototype for the new 18F Standards 3 accreditation, tailored to long axial field-of-view PET/CT scanners.

A valuable step towards harmonised quality standards and quantitative performance assessment for these rapidly evolving models.

Join us at in Vienna for the launch of this new accreditation and to learn more!

07/09/2026

The EANM podcast is officially here! 🎉

We’re excited to announce that the very first episode of Uptake – ’s official podcast – is now available!

In Episode 1, host Mariana Andrade is joined by Paola Anna Erba (EANM President 2025-2026) and Arturo Chiti (Editor-in-Chief of The EANM Journal). Together, they discuss how is evolving beyond diagnosis towards disease interception, and what this could mean for the future of personalised healthcare.

Ready to tune in? Listen now on:

🎧 Amazon Music: https://music.amazon.de/podcasts/5e880ad3-fb00-4707-8c8a-1a7c6b18b31a/episodes/609a4208-8366-4c62-83db-9907f87db229/uptake-the-eanm-podcast-the-future-of-nuclear-medicine-from-diagnosis-to-disease-interception

🎧 Apple Podcasts: https://podcasts.apple.com/us/podcast/the-future-of-nuclear-medicine-from-diagnosis-to/id6807363980?i=1000787861463

🎧 Spotify: https://open.spotify.com/episode/2WL6ZgMSAGdOPWZDheh5J5?si=51cade436a7e44af

🎧 YouTube: https://youtu.be/Qr8VmMh_7lU?si=3E510Pw6AzGiQaLS

04/09/2026

How do the EANM Board and the Policy and Regulatory Affairs Council work together? 🇪🇺

In this clip, Wim Oyen, Chair of the EANM Policy and Regulatory Affairs Council, explains how this collaboration helps EANM make the most of new opportunities.

Join us at the EU Affairs Track and Policy Symposia at to learn more.

📹 Check out the entire episode on our Youtube Channel.
tv

03/09/2026

Can't make it to Vienna? Get a Virtual Access Ticket and join wherever you are. 💻

What's included:
✔️ All 14 CME Sessions and 7 CTE Sessions
✔️ The e-Poster Area
✔️ Live-streamed Satellite Symposia

On-demand until December 21, 2026: catch up anytime and still collect your CME credits.

🔗 https://eanm26.eanm.org/online-registration/

31/08/2026

New publication! 🗞️

A new joint procedural guideline led by on the use of [18F]FDG-PET/CT(A) in large vessel vasculitis and polymyalgia rheumatica is now available in The EANM Journal!

Developed together with the Society of Nuclear Medicine and Molecular Imaging (SNMMI), the American Society of Nuclear Cardiology (ASNC), CANM and the Australian & New Zealand Society of Nuclear Medicine (ANZSNM), and endorsed by CSNM, the guideline brings together multidisciplinary expertise to provide updated recommendations for the use of [18F]FDG-PET/CT(A) in these inflammatory conditions, supporting harmonised imaging practices and contributing to improved patient care in .

Our sincere thank you to all participating societies and authors for their expertise and valuable contributions 🤝

🔗 Access the article: https://www.sciencedirect.com/science/article/pii/S3051292126002277

🔎 Explore all EANM journal articles for free — open access and searchable on Google Scholar.

26/08/2026

EANM is looking for dedicated professionals to support peer review in its journals, The EANM Journal and EANM Innovation 📢

Why become a reviewer? 🔍
️➡️ Contribute to high-quality scientific publishing
➡️ Stay at the forefront of research and innovation
➡️ Strengthen your critical appraisal and research skills
➡️ Be considered for future roles, including Editorial Board Member
➡️ Receive a certificate of recognition issued by EANM

Who are we looking for? 👥
➡️ Experts in clinical and related fields
➡️ Researchers with strong scientific and methodological expertise
➡️ Both early-career and experienced professionals
➡️ Individuals committed to high-quality peer review

🔗 Find out more: https://eanm.org/publications/eanm-journals/become-a-reviewer/

20/08/2026

Big conversations are coming to EANM 🎙️

In just a few weeks, we’ll be launching our very first podcast: Uptake!

Hosted by Mariana Andrade, Uptake will bring together leading experts to explore the breakthroughs shaping the field of .

The first episode drops on September 7, with all future episodes available on Amazon Music, Apple Podcasts, Spotify and YouTube Music. Get ready to tune in! 🎧

🔗 Find out more: https://eanm.org/public-and-media-relations/podcast/

19/08/2026

The 177Lu SPECT/CT accreditation is now open!

This is a new important step towards the standardisation and harmonisation of quantitative 177Lu SPECT/CT.

The accreditation is currently intended for 3/8-inch NaI systems, while centres using 5/8-inch NaI or CZT systems are also welcome to submit data.

Join the growing network of centres contributing to this important initiative in 177Lu imaging!

Find out more and enroll now ➡️ https://earl.eanm.org/177lu-spect-ct/

19/08/2026

The European Nuclear Medicine Day is just around the corner!

and Nuclear Medicine Europe will be hosting their joint in-person event, the 'European Nuclear Medicine Day: Advocating for Better Patient Access and Care', in Brussels on September 29 (13:00–18:00).

This marks a new milestone for both organisations, which are joining forces around one shared goal: advocating for better access to and improved patient care across Europe.

Would you like to take part? Send an e-mail to [email protected] by Monday, August 31. Please note that due to very limited capacity, we may not be able to offer a place to everyone who registers.

📄 Read the joint press release: https://eanm.org/news/european-nuclear-medicine-day-organised-by-eanm-and-nuclear-medicine-europe/

18/08/2026

💡 Tune in this Friday for the ESMIT live webinar in collaboration with the Japanese Society of Nuclear Medicine on “SPECT and PET in the Contemporary Assessment of Cardiac Amyloidosis”!

📅 Date: August 21, 2026
🕐 Time: 12:00 CEST
🎟️ Registration: FREE
🔗 Register here: https://elearning.eanm.org/course/jsnmesmit-live-webinar-spect-and-pet-in-the-contemporary-assessment-of-cardiac-amyloidosis-august-21st-1200-cest

This joint webinar will provide a focused and clinically relevant overview of the role of nuclear medicine in the evaluation of cardiac amyloidosis. The first lecture will address the established value of bone-avid tracer SPECT/CT for non-invasive diagnosis, including acquisition strategy, image interpretation, common pitfalls and integration with the broader diagnostic work-up. The second lecture will explore the evolving contribution of PET, highlighting tracer biology, quantitative opportunities, disease characterization and the potential role of PET for earlier detection and treatment monitoring. Together, the two talks will offer attendees a practical and up-to-date framework for understanding how SPECT and PET can complement each other along the diagnostic and management pathway of patients with suspected or confirmed cardiac amyloidosis.

🎓 Moderator:
Federico Caobelli

🎙️ Speakers:
Takashi Kudo
Pierre-Yves Marie

Join us and !

Adresse

Schmalzhofgasse 26
Vienna
1060

Öffnungszeiten

Montag	09:00 - 17:00
Dienstag	09:00 - 17:00
Mittwoch	09:00 - 17:00
Donnerstag	09:00 - 17:00
Freitag	09:00 - 17:00

Telefon

+4318904427

Webseite

http://www.eanm.org/

Benachrichtigungen

Lassen Sie sich von uns eine E-Mail senden und seien Sie der erste der Neuigkeiten und Aktionen von European Association of Nuclear Medicine - EANM erfährt. Ihre E-Mail-Adresse wird nicht für andere Zwecke verwendet und Sie können sich jederzeit abmelden.